Skip to main content
Caplight Logo









Guangdong Fapon Biopharma Inc.

Guangdong Fapon Biopharma Inc.

Private
DongguanHealthcare & Life Scienceshttps://faponbiopharma.com/

Last Round

Series B

Dec 31, 2020

Est. Valuation

$1.06B

Company Overview

Guangdong Fapon Biopharma Inc. is a biotechnology company that specializes in the discovery and development of biologics for the treatment of cancers and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

biologic therapeuticsantibody discoverybiopharmafusion proteinsT-cell engagerTCEoncology drug developmentCMCchemistry manufacturing and controlsnext-gen biologicsdrug licensingPROTiNbproteolysis targetingAI drug discoverybiotech pipelinedrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Guangdong Fapon Biopharma Inc. Comparables

Compare Guangdong Fapon Biopharma Inc. with similar companies based on industry and business-model similarity.

Guangdong Fapon Biopharma Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EpimAb Biotherapeutics
81%
Innovent Biologics
78%
Suzhou Forlong Biotechnology Co., Ltd.
76%

Guangdong Fapon Biopharma Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 31, 2020
Early FundingJan 1, 2019
Private PlacementMay 10, 2017
Private PlacementAug 18, 2016

Guangdong Fapon Biopharma Inc. Investors

Notable investors and investment history

Guangdong Fapon Biopharma Inc. investors
InvestorRounds
Cathay CapitalSeries B
GL Capital GroupSeries B
Huasheng CapitalSeries B
Dingfeng Asset ManagementPrivate Placement
HongShan Capital Group (HSG)Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 10, 2017

    $1.74M round led by Dingfeng Asset Management

Guangdong Fapon Biopharma Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Guangdong Fapon Biopharma Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Guangdong Fapon Biopharma Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersDongguan
Employee Range13
Year Founded2015
Last FundingDec 31, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?